RCKT β€” ROCKET PHARMACEUTICALS INC

Ownership history in Virtu Financial LLC  Β·  4 quarters on record

This page tracks every 13F SEC filing in which Virtu Financial LLC reported a position in ROCKET PHARMACEUTICALS INC (RCKT). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price β€” sourced directly from SEC EDGAR 13F filings.

πŸ” Peak position
0.03% (2023 Q4)
πŸ“Š Avg. % of fund
0.02%
πŸ“… First filed
2020 Q4
πŸ“… Last filed
2025 Q3
⏱ Quarters held
4

Position Intelligence

Virtu Financial LLC Γ— RCKT AI Analytics

πŸ“‰ Virtu Financial LLC underperformed the S&P 500 by –235.1% annually on this RCKT position. Timing score: 67% (2/3 decisions correct). Average cost basis: $28.11. Maximum drawdown during holding period: –94.1%.

πŸ“ˆ Position Alpha vs SPY
-235.1%
annualised excess return

❌ Significantly underperformed the S&P 500 by 235.1% ann.
3 quarters analyzed

⏱️ Timing Score
67%

βœ… Decent timing β€” more right than wrong on entries and exits.
2 of 3 add/trim decisions correct

πŸ’° Entry Quality
$28.11
-88.4% vs current ($3.26)

Best entry: $3.26 (2025 Q3)  Β·  Worst: $54.84 (2020 Q4)

πŸ›‘οΈ Drawdown Resilience
–94.1%
max drawdown while held

πŸ’ͺ Held through 1 major drawdown (>20%). Strong conviction under pressure.

πŸ’ͺ Fund Conviction
75%
buy-side decisions

3 adds Β· 1 trim. Bought during 2 of 2 down-price quarters. πŸ‚ Consistently bullish β€” fund kept accumulating this position.

πŸ“‘ Position Trajectory
β†’ Stable
last 4–5 quarters trend

βš–οΈ Portfolio weight has remained relatively stable β€” conviction maintained.
Currently 0.0% of portfolio

⚠ Based on quarterly 13F SEC filings and end-of-quarter closing prices. Timing score = accuracy of add/trim decisions vs next-quarter price direction. Alpha = mean quarterly excess return Γ— 4 (annualised). Not investment advice.

% of Fund (quarterly)    RCKT price (monthly, adj. close)
πŸ“‹ Quarterly Holdings History 4 quarters  β–Ύ
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 12,386 +1,314 +11.9% 0.00% $40K $3.26
2023 Q4 REDUCED 11,072 -3,363 -23.3% 0.03% $332K $29.97
2023 Q2 ADDED 14,435 +10,100 +233.0% 0.02% $287K $19.87
2020 Q4 INITIATED 4,335 β€” β€” 0.03% $238K $54.84

🏒 Other funds also holding RCKT

As of 2025 Q4 β€” sorted by position size

Monaco Asset Management SAM 3Y 1.82% Lion Point Capital, LP 3Y 7Y 1.56% M28 Capital Management LP 3Y 0.98% Newtyn Management, LLC 3Y 7Y 0.98% Amitell Capital Pte Ltd 3Y 0.7% MPM BioImpact LLC 3Y 0.64% RTW INVESTMENTS, LP 3Y 7Y 0.62% Prosight Management, LP 3Y 7Y 0.54% Opaleye Management Inc. 3Y 7Y 0.44% MONIMUS CAPITAL MANAGEMENT, LP 0.32%
← Back to Virtu Financial LLC Holdings